Radical mastectomy

Last updated
Radical mastectomy
William Stewart Halsted, Surgical papers Wellcome L0004968.jpg
Radical Mastectomy

Radical mastectomy is a surgical procedure that treats breast cancer by removing the breast and its underlying chest muscle (including pectoralis major and pectoralis minor), and lymph nodes of the axilla (armpit). Breast cancer is the most common cancer among women. During the early twentieth century it was primarily treated by surgery, when the mastectomy was developed. [1] However, with the advancement of technology and surgical skills in recent years, mastectomies have become less invasive. [2] As of 2016, a combination of radiotherapy and breast conserving mastectomy are considered optimal treatment.

Contents

Radical mastectomy

Portrait of William Halsted William Stewart Halsted.jpg
Portrait of William Halsted
Pectoralis Major Pectoralis major.png
Pectoralis Major

Halsted and Meyer were the first to achieve successful results with the radical mastectomy, thus ushering in the modern era of surgical treatment for breast cancer. In 1894, William Halsted published his work with radical mastectomy from the 50 cases operated at Johns Hopkins between 1889 and 1894. [3] Willy Meyer also published research on radical mastectomy from his interactions with New York patients in December 1894. [4] The en bloc removal of the breast tissue became known as the Halsted mastectomy before adopting the title "the complete operation" and eventually, "the radical mastectomy" as it is known today. [5]

Radical mastectomy was based on the medical belief at the time that breast cancer spread locally at first, invading nearby tissue and then spreading to surrounding lymph ducts where the cells were "trapped". It was thought that hematic spread of tumor cells occurred at a much later stage. [1] Halsted himself believed that cancer spread in a "centrifugal spiral", solidifying this opinion in the medical community at the time. [6]

Radical mastectomy involves removing all the breast tissue, overlying skin, the pectoralis muscles, and all the axillary lymph nodes. Skin was removed because the disease involved the skin, which was often ulcerated. [3] [7] The pectoralis muscles were removed not only because the chest wall was involved, but also because it was thought that removal of the transpectoral lymphatic pathways were necessary. It was also thought, at that time, that it was anatomically impossible to do a complete axillary dissection without removing the pectoralis muscle. [3] [4]

William Halsted accomplished a three-year recurrence rate of 3% and a locoregional recurrence rate of 20% with no perioperative mortality. The five-year survival rate was 40%, which was twice that of untreated patients. [3] However, post-operation morbidity rates were high as the large wounds were left to heal by granulation, lymphedema was ubiquitous, and arm movement was highly restricted. Thus, chronic pain became a prevalent sequela. Because surgeons were faced with such large breast cancers that seemed to need drastic treatment methods, the quality of patient life was not taken into consideration. [7] [8] [9] [10] [11] [12] [13] [ excessive citations ]

Nonetheless, due to Halsted and Meyer's work, it was possible to cure some cases of breast cancer and knowledge of the disease began to increase. Standardized treatments were created, and controlled long-term studies were conducted. Soon, it became apparent that some women with advanced stages of the disease did not benefit from surgery. In 1943, Haagensen and Stout reviewed over 500 patients who had radical mastectomy for breast cancer and identified a group of patients who could not be cured by radical mastectomy thus developing the concepts of operability and inoperability. [14] The signs of inoperability included ulceration of the skin, fixation to the chest wall, satellite nodules, edema of the skin (peau d'orange), supraclavicular lymph node enlargement, axillary lymph nodes greater than 2.5 cm, or matted, fixed lymph nodes. [14] This contribution of Haagensen and his colleagues would eventually lead to the development of a clinical staging system for breast cancer, the Columbia Clinical Classification, which is a landmark in the study of biology and treatment of breast cancer.[ citation needed ]

Today, surgeons rarely perform radical mastectomies, as a 1977 study by the National Surgical Adjuvant Breast and Bowel Project (NSABP), led by Bernard Fisher, showed that there was no statistical difference in survival or recurrence between radical mastectomies and less invasive surgeries. [15] [16]

Extended radical mastectomies

According to the Halsted-Meyer theory, the major pathway for breast cancer dissemination was through the lymphatic ducts. Therefore, it was thought that performing wider and more mutilating surgeries that removed a greater number of lymph nodes would result in greater chances of cure. [17] From 1920 onwards, many surgeons performed surgeries more invasive than the original procedure by Halsted. Sampson Handley noted Halsted's observation of the existence of malignant metastasis to the chest wall and breast bone via the chain of internal mammary nodes under the sternum and employed an "extended" radical mastectomy that included the removal of the lymph nodes located there and the implantation of radium needles into the anterior intercostal spaces. [18] This line of study was extended by his son, Richard S. Handley, who studied internal mammary chain nodal involvement in breast cancer and demonstrated that 33% of 150 breast cancer patients had internal mammary chain involvement at the time of surgery. [19] The radical mastectomy was subsequently extended by a number of surgeons such as Sugarbaker and Urban to include removal of internal mammary lymph nodes. [20] [21] Eventually, this "extended" radical mastectomy was extended even further to include removal of the supraclavicular lymph nodes at the time of mastectomy by Dahl-Iversen and Tobiassen. [22] Some surgeons like Prudente even went as far as amputating the upper arm en bloc with the mastectomy specimen in an attempt to cure relatively advanced local disease. [23] This increasingly radical progression culminated in the ‘super-radical’ mastectomy which consisted of complete excision of all breast tissue, axillary content, removal of the latissimus dorsi, pectoralis major and minor muscles and dissection of the internal mammary lymph nodes. [24] After retrospective analysis, the extended radical mastectomies were abandoned as these massive and disabling operations proved to be not superior to those of the standard radical mastectomies.[ citation needed ]

Related Research Articles

<span class="mw-page-title-main">Breast reconstruction</span> Surgical rebuilding of a breast

Breast reconstruction is the surgical process of rebuilding the shape and look of a breast, most commonly in women who have had surgery to treat breast cancer. It involves using autologous tissue, prosthetic implants, or a combination of both with the goal of reconstructing a natural-looking breast. This process often also includes the rebuilding of the nipple and areola, known as nipple-areola complex (NAC) reconstruction, as one of the final stages.

<span class="mw-page-title-main">Lymphedema</span> Medical condition

Lymphedema, also known as lymphoedema and lymphatic edema, is a condition of localized swelling caused by a compromised lymphatic system. The lymphatic system functions as a critical portion of the body's immune system and returns interstitial fluid to the bloodstream.

<span class="mw-page-title-main">Mastectomy</span> Surgical removal of one or both breasts

Mastectomy is the medical term for the surgical removal of one or both breasts, partially or completely. A mastectomy is usually carried out to treat breast cancer. In some cases, women believed to be at high risk of breast cancer have the operation as a preventive measure. Alternatively, some women can choose to have a wide local excision, also known as a lumpectomy, an operation in which a small volume of breast tissue containing the tumor and a surrounding margin of healthy tissue is removed to conserve the breast. Both mastectomy and lumpectomy are referred to as "local therapies" for breast cancer, targeting the area of the tumor, as opposed to systemic therapies, such as chemotherapy, hormonal therapy, or immunotherapy.

<span class="mw-page-title-main">Breast cancer</span> Cancer that originates in mammary glands

Breast cancer is a cancer that develops from breast tissue. Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, milk rejection, fluid coming from the nipple, a newly inverted nipple, or a red or scaly patch of skin. In those with distant spread of the disease, there may be bone pain, swollen lymph nodes, shortness of breath, or yellow skin.

<span class="mw-page-title-main">Breast augmentation</span> Surgical procedure

Breast augmentation and augmentation mammoplasty is a cosmetic surgery technique using breast-implants and fat-graft mammoplasty techniques to increase the size, change the shape, and alter the texture of the breasts. Augmentation mammoplasty is applied to correct congenital defects of the breasts and the chest wall. As an elective cosmetic surgery, primary augmentation changes the aesthetics – of size, shape, and texture – of healthy breasts.

<span class="mw-page-title-main">Paget's disease of the breast</span> Medical condition

Paget's disease of the breast is a rare skin change at the nipple nearly always associated with underlying breast cancer. Paget's disease of the breast was first described by Sir James Paget in 1874. The condition is an uncommon disease accounting for 1 to 4% of all breast cancers cases. 92% to 100% of patients with Paget's disease of the breast have an underlying breast cancer.

<span class="mw-page-title-main">Lymphadenectomy</span> Medical procedure

Lymphadenectomy, or lymph node dissection, is the surgical removal of one or more groups of lymph nodes. It is almost always performed as part of the surgical management of cancer. In a regional lymph node dissection, some of the lymph nodes in the tumor area are removed; in a radical lymph node dissection, most or all of the lymph nodes in the tumor area are removed.

<span class="mw-page-title-main">Lumpectomy</span> Limited surgical removal of breast tissue

Lumpectomy is a surgical removal of a discrete portion or "lump" of breast tissue, usually in the treatment of a malignant tumor or breast cancer. It is considered a viable breast conservation therapy, as the amount of tissue removed is limited compared to a full-breast mastectomy, and thus may have physical and emotional advantages over more disfiguring treatment. Sometimes a lumpectomy may be used to either confirm or rule out that cancer has actually been detected. A lumpectomy is usually recommended to patients whose cancer has been detected early and who do not have enlarged tumors. Although a lumpectomy is used to allow for most of the breast to remain intact, the procedure may result in adverse affects that can include sensitivity and result in scar tissue, pain, and possible disfiguration of the breast if the lump taken out is significant. According to National Comprehensive Cancer Network guidelines, lumpectomy may be performed for ductal carcinoma in situ (DCIS), invasive ductal carcinoma, or other conditions.

<span class="mw-page-title-main">Invasive carcinoma of no special type</span> Medical condition

Invasive carcinoma of no special type, invasive breast carcinoma of no special type (IBC-NST), invasive ductal carcinoma (IDC), infiltrating ductal carcinoma (IDC) or invasive ductal carcinoma, not otherwise specified (NOS) is a disease. For international audiences this article will use "invasive carcinoma NST" because it is the preferred term of the World Health Organization (WHO).

<span class="mw-page-title-main">William Stewart Halsted</span> American surgeon (1852–1922)

William Stewart Halsted, M.D. was an American surgeon who emphasized strict aseptic technique during surgical procedures, was an early champion of newly discovered anesthetics, and introduced several new operations, including the radical mastectomy for breast cancer. Along with William Osler, Howard Atwood Kelly and William H. Welch, Halsted was one of the "Big Four" founding professors at the Johns Hopkins Hospital. His operating room at Johns Hopkins Hospital is in Ward G, and was described as a small room where medical discoveries and miracles took place. According to an intern who once worked in Halsted's operating room, Halsted had unique techniques, operated on the patients with great confidence and often had perfect results which astonished the interns.

<span class="mw-page-title-main">Sentinel lymph node</span> First lymph node to receive drainage from a primary tumor

The sentinel lymph node is the hypothetical first lymph node or group of nodes draining a cancer. In case of established cancerous dissemination it is postulated that the sentinel lymph nodes are the target organs primarily reached by metastasizing cancer cells from the tumor.

<span class="mw-page-title-main">Axillary lymph nodes</span> Lymph nodes in the human armpit

The axillary lymph nodes or armpit lymph nodes are lymph nodes in the human armpit. Between 20 and 49 in number, they drain lymph vessels from the lateral quadrants of the breast, the superficial lymph vessels from thin walls of the chest and the abdomen above the level of the navel, and the vessels from the upper limb. They are divided in several groups according to their location in the armpit. These lymph nodes are clinically significant in breast cancer, and metastases from the breast to the axillary lymph nodes are considered in the staging of the disease.

Breast cancer management takes different approaches depending on physical and biological characteristics of the disease, as well as the age, over-all health and personal preferences of the patient. Treatment types can be classified into local therapy and systemic treatment. Local therapy is most efficacious in early stage breast cancer, while systemic therapy is generally justified in advanced and metastatic disease, or in diseases with specific phenotypes.

<span class="mw-page-title-main">Breast-conserving surgery</span> Surgical operation

Breast-conserving surgery refers to an operation that aims to remove breast cancer while avoiding a mastectomy. Different forms of this operation include: lumpectomy (tylectomy), wide local excision, segmental resection, and quadrantectomy. Breast-conserving surgery has been increasingly accepted as an alternative to mastectomy in specific patients, as it provides tumor removal while maintaining an acceptable cosmetic outcome. This page reviews the history of this operation, important considerations in decision making and patient selection, and the emerging field of oncoplastic breast conservation surgery.

Breast surgery is a form of surgery performed on the breast.

<span class="mw-page-title-main">Male breast cancer</span> Medical condition

Male breast cancer (MBC) is a cancer in males that originates in their breasts. Males account for less than 1% of new breast cancers with about 20,000 new cases being diagnosed worldwide every year. Its incidence rates in males vs. females are, respectively, 0.4 and 66.7 per 100,000 person-years. The worldwide incidences of male as well as female breast cancers have been increasing over the last few decades. Currently, one of every 800 men are estimated to develop this cancer during their lifetimes.

Axillary dissection is a surgical procedure that incises the axilla, usually in order to identify, examine, or take out lymph nodes. The term "axilla" refers to the armpit or underarm section of the body. The axillary dissection procedure is commonly used in treating the underarm portion of women who are dealing with breast cancer. The lymph nodes located in the axilla area that are affected by breast cancer are called the guardian or sentinel lymph nodes. Lymph nodes are essential to the lymphatic/immune system due to their main function of filtering unrecognized particles and molecules. The idea of treating breast cancer with the axillary dissection procedure was introduced in the 18th century and was backed by German physician Lorenz Heister. There are certain criteria that make patients eligible candidates for this procedure. Patients tend to have three different levels of axillary lymph nodes; the level helps to determine whether or not the patient should undergo axillary dissection.

<span class="mw-page-title-main">Armando E. Giuliano</span> American surgical oncologist

Armando Elario Giuliano is a surgical oncologist, surgeon scientist and medical professor in Los Angeles, California, United States of America. He is the Linda and Jim Lippman Chair in Surgical Oncology and co-director of Saul and Joyce Brandman Breast Center at Cedars-Sinai Medical Center, Los Angeles.

Aesthetic flat closure after mastectomy is contouring of the chest wall after mastectomy without traditional breast reconstruction. Vernacular synonyms and related vernacular and technical terms include "going flat", "flat closure", "optimal flat closure", "nonreconstructive mastectomy", "oncoplastic mastectomy", "non-skin sparing mastectomy", "mastectomy without reconstruction", and "aesthetic primary closure post-mastectomy".

Mammary secretory carcinoma (MSC), also termed secretory carcinoma of the breast, is a rare form of the breast cancers. MSC usually affects women but in a significant percentage of cases also occurs in men and children. Indeed, McDvitt and Stewart first described MSC in 1966 and termed it juvenile breast carcinoma because an increased number of cases were at that time diagnosed in juvenile females. MSC is the most common form of breast cancer in children, representing 80% of childhood breast cancers, although it accounts for less than 0.15% of all breast cancers.

References

  1. 1 2 Zurrida, Stefano; Bassi, Fabio; Arnone, Paolo; Martella, Stefano; Castillo, Andres Del; Martini, Rafael Ribeiro; Semenkiw, M. Eugenia; Caldarella, Pietro (2011-06-05). "The Changing Face of Mastectomy (from Mutilation to Aid to Breast Reconstruction)". International Journal of Surgical Oncology. 2011: 980158. doi: 10.1155/2011/980158 . ISSN   2090-1402. PMC   3263661 . PMID   22312537.
  2. ↑ Plesca M, Bordea C, El Houcheimi B, Ichim E, Blidaru A (2016). "Evolution of radical mastectomy for breast cancer". J Med Life. 9 (2): 183–6. ISSN   1844-3117. PMC   4863512 . PMID   27453752.
  3. 1 2 3 4 Halsted, William S. (1894-11-01). "I. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894". Annals of Surgery. 20 (5): 497–555. doi:10.1097/00000658-189407000-00075. ISSN   0003-4932. PMC   1493925 . PMID   17860107.
  4. 1 2 W. Meyer, "An improved method of the radical operation for carcinoma of the breast", New York Medical Record, vol. 46, pp. 746–749, 1894.
  5. ↑ Sakorafas, G.h.; Safioleas, Michael (2010-01-01). "Breast cancer surgery: an historical narrative. Part II. 18th and 19th centuries". European Journal of Cancer Care. 19 (1): 6–29. doi: 10.1111/j.1365-2354.2008.01060.x . ISSN   1365-2354. PMID   19674073.
  6. ↑ Newmark, J.J. (2016). "No ordinary meeting': Robert McWhirter and the decline of radical mastectomy". The Journal of the Royal College of Physicians of Edinburgh. 46 (1): 43–48. doi:10.4997/jrcpe.2016.110. PMID   27092369.
  7. 1 2 HALSTED, WILLIAM STEWART (1913-02-08). "Developments in the Skin-Grafting Operation for Cancer of the Breast". JAMA: The Journal of the American Medical Association. 60 (6): 416. doi:10.1001/jama.1913.04340060008004. ISSN   0002-9955.
  8. ↑ Riddell, V. H. (2017-04-21). "The Technique of Radical Mastectomy: With Special Reference to the Management of the Skin Short Case and the Prevention of Functional Disability". British Journal of Cancer. 4 (3): 289–297. doi:10.1038/bjc.1950.27. ISSN   0007-0920. PMC   2007674 . PMID   14783660.
  9. ↑ Neumann, Charles G.; Conway, Herbert (1948-01-01). "Evaluation of skin grafting in the technique of radical mastectomy in relation to function of the arm". Surgery. 23 (3): 584–90. ISSN   0039-6060. PMID   18906044.
  10. ↑ Bard, Morton (2017-04-21). "The sequence of emotional reactions in radical mastectomy patients". Public Health Reports. 67 (11): 1144–1148. doi:10.2307/4588308. ISSN   0094-6214. JSTOR   4588308. PMC   2030852 . PMID   12993982.
  11. ↑ Parker, Joe M.; Russo, P. E.; Oesterreicher, D. L. (1952). "Investigation of Cause of Lymphedema of the Upper Extremity After Radical Mastectomy". Radiology. 59 (4): 538–545. doi:10.1148/59.4.538. PMID   12983584.
  12. ↑ JR, VON RONNEN (1955-01-01). "[Spontaneous rib fractures after radical mastectomy]". Journal Belge de Radiologie. 38 (4): 525–34. ISSN   0302-7430. PMID   13331884.
  13. ↑ Fitts WT, Keuhnelian JG, Ravdin IS, Schor S (March 1954). "Swelling of the arm after radical mastectomy; a clinical study of its causes". Surgery. 35 (3): 460–64. PMID   13146467.
  14. 1 2 Townsend, Courtney; Abston, Sally; Fish, Jay (May 1985). "Surgical Adjuvant Treatment of Locally Advanced Breast Cancer". Ann Surg. 201 (5): 604–10. doi:10.1097/00000658-198505000-00009. PMC   1250769 . PMID   3994434.
  15. ↑ Fisher, B.; Montague, E.; Redmond, C.; Barton, B.; Borland, D.; Fisher, E. R.; Deutsch, M.; Schwarz, G.; Margolese, R. (June 1977). "Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial". Cancer. 39 (6 Suppl): 2827–2839. doi:10.1002/1097-0142(197706)39:6<2827::aid-cncr2820390671>3.0.co;2-i. ISSN   0008-543X. PMID   326381.
  16. ↑ Mukherjee, Siddhartha (2011). The Emperor of All Maladies . New York, NY: Simon & Schuster. pp.  200–201. ISBN   978-1-4391-0795-9.
  17. ↑ Carey, J.M.; Kirklin, J.W. (1952-10-01). "Extended radical mastectomy: a review of its concepts". Proceedings of the Staff Meetings of the Mayo Clinic. 27 (22): 436–40. ISSN   0092-699X. PMID   13004011.
  18. ↑ Schachter, Karen; Neuhauser, Duncan (1981). Surgery for breast cancer. DIANE Publishing. ISBN   9781428924581.
  19. ↑ Handley, R. S.; Thackray, A. C. (1954-01-09). "Invasion of Internal Mammary Lymph Nodes in Carcinoma of the Breast". British Medical Journal. 1 (4853): 61–63. doi:10.1136/bmj.1.4853.61. ISSN   0007-1447. PMC   2093179 . PMID   13106471.
  20. ↑ Sugarbaker, E. D. (1953-09-01). "Radical mastectomy combined with in-continuity resection of the homolateral internal mammary node chain". Cancer. 6 (5): 969–979. doi: 10.1002/1097-0142(195309)6:5<969::aid-cncr2820060516>3.0.co;2-5 . ISSN   0008-543X. PMID   13094645.
  21. ↑ Urban, J. A. (1964-03-01). "Surgical excision of internal mammary nodes for breast cancer". The British Journal of Surgery. 51 (3): 209–212. doi:10.1002/bjs.1800510311. ISSN   0007-1323. PMID   14129436. S2CID   5680572.
  22. ↑ Dahl-Iversen, E.; Tobiassen, T. (1969-12-01). "Radical mastectomy with parasternal and supraclavicular dissection for mammary carcinoma". Annals of Surgery. 170 (6): 889–891. doi:10.1097/00000658-196912000-00006. ISSN   0003-4932. PMC   1387715 . PMID   5352643.
  23. ↑ PACK, GEORGE T. (1961-11-01). "Interscapulomammothoracic Amputation for Malignant Melanoma". Archives of Surgery. 83 (5): 694–9. doi:10.1001/archsurg.1961.01300170050010. ISSN   0004-0010. PMID   14483062.
  24. ↑ "Super Radical Mastectomy". TheFreeDictionary.com. Retrieved 2017-04-02.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.